glp 16&1 GLP-1 RA Adherence Shows Drop-Off After 1 Year GLP-1s: What They Are and

As a result, many patients experience: Reduced appetite Improved satiety Better metabolic regulation Gradual, sustainable weight loss Semaglutide and tirzepatide are two of the most widely discussed medications in this category

Broader adoption requires careful evaluation of safety, cost, and evidence for less-established indications

Notably, although there was not a statistically significant increase in biliary disease among GLP-1 receptor agonist users in this study, the FDA 2 added warnings and precautions about acute cholecystitis and biliary disease to the label in late 2022 based on data from placebo-controlled RCTs as well as other observational data 3

2024 Jan;30(1):168-176

These patients should be followed more closely ( Table 1 )

Sequences of receptor clones were confirmed by DNA sequencing